Zai Lab Ltd.

Zai Lab Ltd. Sponsored ADR's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Zai Lab Ltd. Sponsored ADR has 114.69M shares outstanding.

As of June 30, 2026, Zai Lab Ltd. Sponsored ADR maintains a current ratio of 2.13, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 41.94, indicating elevated leverage, while an interest coverage ratio of -41.46 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Zai Lab Ltd. Sponsored ADR posted a negative return on equity (ROE) of -26.91, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -16.81, reflecting losses generated across the asset base. The company generates approximately 4.35M in revenue per employee across its workforce of 1,805.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.57 indicates how many times Zai Lab Ltd. Sponsored ADR sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Zai Lab Ltd. Sponsored ADR recorded an income tax benefit of -43.84M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -3.33B and -3.29B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on September 18, 2026, Zai Lab Ltd. Sponsored ADR's stock has gained approximately 0.00% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Zai Lab Ltd. Sponsored ADR generated 7.86B in revenue and converted that into -3.29B in net income, yielding earnings per share of -29.20. EBITDA reached -4.34B, while operating income came in at -4.58B.

As of June 30, 2026, Zai Lab Ltd. Sponsored ADR holds 10.79B in cash and equivalents against 4.45B in total debt, resulting in a net debt position of -6.45B. Total book value stands at 10.61B, with working capital of 8.48B providing operational flexibility.

Zai Lab Ltd. Sponsored ADR produced -2.33B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -509.02M in capital expenditures, free cash flow totaled -2.84B - equivalent to -25.21 per share.

Over the twelve months ended June 30, 2026, Zai Lab Ltd. Sponsored ADR posted a gross margin of 56.47, reflecting its pricing power and cost economics. The operating margin of -58.27 and net profit margin of -41.86 provide insight into operational efficiency.